Challenges and difficulties faced by huarui pharmaceutical industry.

At 1. 1982, China and Sweden signed a contract with Huarui Pharmaceutical.

2. 1983, the foundation stone was laid for Huarui Pharmaceutical Wuxi Factory.

3.1Feb. 986, Ms. Zhou of Shanghai had her small intestine totally removed due to acute volvulus. With the selfless support of Huarui Pharmaceutical, she became the first patient in China to rely entirely on total parenteral nutrition infusion to maintain her life.

4. 1987 On April 9th, Huarui Pharmaceutical held a grand opening ceremony. Swedish Prime Minister Carlsson attended the opening ceremony and wrote an inscription: "An important moment in Sino-Swedish relations".

5.1On April 8th, 992, Zhou gave birth to a daughter, becoming the first baby conceived by parenteral total nutrition infusion in the world, and was recorded in the Guinness Book of World Records.

6.1In July 1992, Huarui Pharmaceutical won the second prize of scientific and technological progress of the Ministry of Health.

7. 1995, the foundation stone was laid for the second phase of Huarui Pharmaceutical Factory.

8. 1995, Huarui Pharmaceutical was rated as one of the top ten joint venture pharmaceutical enterprises by the State Administration of Medicine.

9. 1994- 1996, Huarui Pharmaceutical was rated as a national enterprise with excellent foreign investment.

10.1998 In April, Huarui Pharmaceutical passed the GMP certification of China Ministry of Health.

11.1.998 In June, the second phase of Huarui Pharmaceutical Factory with a total investment of nearly 300 million yuan was completed, which marked the birth of a large infusion production line in China pharmaceutical industry that reached the world advanced level at the beginning of the second century, with an annual production capacity of130,000 bottles.

12.1On August 3, 1999, the 30th Board of Directors of Huarui Pharmaceutical announced that Fei Sen Yuska Company had become the foreign shareholder of the company.

13.in June 2000, the second phase factory passed the GMP certification of China.

14. On March 20th, 2000, Huarui Pharmaceutical passed the ISO 1400 1 certification organized by Huaxia Environmental Management System Audit Center of State Environmental Protection Administration and UKAS of Britain respectively.

15. On June 6, 2000, 16 and February 27, 2000, Huarui Pharmaceutical's large infusion and small needle production lines passed the EU GMP certification respectively.

16 August. On 200 1, Huarui Pharmaceutical's enteral nutrition products were listed in Julie and Gao Rui, and Huarui became the only company in China that can provide enteral and parenteral nutrition products and services.

17.2001September 12, Huarui Pharmaceutical received the first batch of orders for exporting 500 bottles 10%500ML of epeetabine to Bangladesh, thus breaking the record of zero export of large infusion in China.

18.200 1 1 June11,Huarui Pharmaceutical signed the first large infusion order in history, with 650,000 bottles of 20%250ML etoposide and 20%500ML exported to Europe and France.

19. In 2002, Huarui Pharmaceutical won the "Double Excellent" Award for Foreign-invested Enterprises in 2002.

20. On June 65438+1October 65438+June 6, 2002, Huarui Pharmaceutical's annual marketing conference was held in Bangkok, Thailand, which was the first time for the company to hold a large-scale internal conference abroad.

21.On March1-15, 2002, Huarui Pharmaceutical accepted the EU GMP examination and obtained the GMP certification on May 17.

On April 4th, 2002, the first batch of 38,400 bottles of Loewell water were airlifted from Shanghai to Stockholm, Sweden, which marked the official start of Loewell water export business. Huarui Pharmaceutical Co., Ltd. became the first domestic enterprise to export freeze-dried powder for injection to the European market, and made another historic breakthrough.

23. In July 2002, 30% of IPPIT products were rated as national key new products.

24. In August 2002, Andamei, Leshuiwei Tata, 30% Fearless, Lefanming and Li Neng MCT were rated as high-tech products by Jiangsu Province.

25. In September 2002, the newly-built oral emulsion production line passed the GMP certification of China.

26.5438 June +20021October, 30% of IPPIT won the third prize of Jiangsu Science and Technology Progress.

27. In June 2002, Huarui Pharmaceutical was awarded as a high-tech enterprise in Jiangsu Province.

28. In April, 2003, Huarui Pharmaceutical was awarded as the key high-tech enterprise of the National Torch Program.

29. In April 2003, the project of total enteral nutrition emulsion was included in the national torch plan.

In April 2003, Ruineng and Julie were rated as national key new products.

On March 31.200310/October 18, Huarui Pharmaceutical officially moved its management headquarters to floor 18 of China Resources Building, Jianguomen, Beijing.

32. On February 8th, 2003, 65438+ Fei Sen Juska compared with the new CEO Mark? Mr. Markus Schneider visited Huarui Wuxi factory and Beijing headquarters.

33. In 2004, Huarui Pharmaceutical was awarded the green grade enterprise of environmental behavior information disclosure in Jiangsu Province.

In July, 2004, Li Neng was rated as a national key new product.

35. In July 2004, Huarui Pharmaceutical Company listed the first three-cavity bag product in China.

On September 7th, 2004, Huarui Company passed the biennial review of high-tech enterprises and technology-intensive and knowledge-intensive enterprises in Jiangsu Province.

37.2004124-26 October, 165438+ Huarui Company successfully passed the EU's biennial GMP certification review.

38. On June 5438+February 65438+August 20, 2004, the sterile drugs of Huarui Company successfully passed the GMP certification examination organized by the US Food and Drug Administration.

On February 9th, 2004-10, Huarui Company successfully passed the ISO 1400 1 audit organized by Huaxia Certification Center.

40. On February 6, 2005, Lofuming (compound amino acid injection and its manufacturing method) was authorized by the national invention patent.

4 1. On March12005, the State Food and Drug Administration of the United States issued the Notice on Launching the Pilot Work of Drug Parameter Release, and Huarui Company was listed as one of the two pilot enterprises in China for two years.

42. On March 7th, 2005, Huarui Company obtained the License of Medical Enterprise Operation, which indicated that the company obtained the right to operate medical devices and further expanded its business field.

43. In June 2005, the national sales volume of Calvin exceeded 65,438+00,000 packs.

In June 2005, Ruixian was recognized as a national key new product.

45. On February 28th, 2005, People's Republic of China (PRC) Ministry of Commerce approved Fei Sen Giant Scarby Co., Ltd to transfer its 5 1% equity of Huarui Company to Fei Sen Giant Scarby (China) Investment Co., Ltd.

46. On May 6th, 2006, Li Lanqing, former executive vice premier of The Politburo Standing Committee (PSC) and the State Council, accompanied by provincial and municipal leaders, inspected Huarui Company and held a symposium for the heads of Sino-foreign joint ventures in Suzhou, Wuxi and Changzhou in Huarui conference room.

47. In June 2006, Huarui Company passed the review of key high-tech enterprises in the National Torch Program.

48. In June, 2006, Huarui Company passed the review of high-tech enterprises in Jiangsu Province.

49. In June 2006, Le Fanming was recognized as a national key new product.

In 2006, Huarui Company was awarded the highest comprehensive award by Wuxi Municipal People's Government-"Tengfei Award".

51.In February 2006, 65438+2, Huarui Company passed the evaluation of technology-intensive and knowledge-intensive enterprises in Jiangsu Province.

52. On February 20th, 2006, 65438+2006, Julie (fiber-free enteral total nutrition preparation and its manufacturing method) and Ruineng (tumor patient enteral total nutrition preparation and its manufacturing method) were granted national invention patents.

53. On March 30-3 1 2007, Huarui Company passed the on-site inspection of parameter release of Jiangsu American Food and Drug Administration.

54. On May 6th, 2007, 5438+May, Huarui Company was awarded "Advanced Technology Enterprise with Foreign Investment" by Jiangsu Province.

55. On May 30th, 2007, Chaihu Oil Emulsion Injection and its production method were authorized by the national invention patent.

On October 24th, 2007, the 25th anniversary celebration of Huarui Pharmaceutical Co., Ltd. was held in the Great Hall of the People in Wuxi.

57. In June, 2008, 5438+ 10 was recognized as a famous trademark in Jiangsu Province, and Interlipiter was awarded the title of "Famous Brand Product in Jiangsu Province".

58. On March 5th, 2008, Huarui Wuxi Factory successfully passed the ISO900 1 certification inspection organized by TUV, Germany, and obtained the certificate.

59. On March 25th, 2008, Huarui Wuxi Factory successfully passed the ISO 1400 1 audit organized by TUV in Germany and obtained the certification.

60. On September 26th, 2008, the foundation stone was laid for the third phase of Huarui Company.

6 1.20081October 2 1 day, Huarui Company successfully passed the high-tech enterprise certification again, and obtained the high-tech enterprise certificate jointly issued by Jiangsu Science and Technology Department, Jiangsu Finance Department, Jiangsu State Taxation Bureau and Jiangsu Local Taxation Bureau.

62. On June 5438+February 65438+February 2008, "Composition and preparation method of structured fat emulsion amino acid glucose injection packaged in three-cavity bags" was authorized by the national invention patent.

June 63.5438+February 2008, Huarui Company was awarded the title of "Excellent Enterprise in the 30th Anniversary of Reform and Opening-up in Wuxi" by Wuxi Municipal Party Committee and Wuxi Municipal People's Government. All rivers run into the sea and there are many talents, which is a vivid portrayal of Huarui Pharmaceutical Co., Ltd. (hereinafter referred to as Huarui)' s talent view. Huarui attaches great importance to the development of human resources, insists on "people-oriented, knowing people and making good use of them" and advocates the establishment of a learning organization. Huarui invests millions of yuan in special training for employees every year, sends outstanding employees to study abroad, and successfully trains a large number of outstanding talents specializing in product research and development, production, quality management and marketing. Huarui has also launched the "Core Employee Plan", which selects young employees with outstanding work and potential from all departments, increases the intensity and depth of training in a targeted manner, gives more development space and exercise opportunities, realizes the rational allocation of training resources, and greatly enhances the core competitiveness of enterprises.

Huarui combines advanced production management technology with traditional humanistic spirit, advocates morality and encourages cooperation, forming a unique cultural charm and working atmosphere. Under the careful arrangement of trade unions and party organizations, employees' spare time life is rich and colorful, including photography associations, riders' associations, sports leagues, calligraphy and painting competitions, outward bound training, visits to revolutionary resorts, etc ... Every Huarui employee deeply loves his work, his like-minded partners and Huarui Company, which is as warm as home and full of infinite vitality. They are willing to closely associate their personal development with the name Huarui and look forward to China Medical Nutrition. 1March, 1998, the company donated/kloc-0.50 million yuan to establish "Huarui Hope Primary School" in huangling county, Yan 'an, and continuously organized employees to visit and donate teachers and students there.

In September, 1998, the company donated medicines worth 2 million yuan to teachers and students in Hunan and Hubei where floods occurred.

Symphony concerts were held in Wuxi in 2000 and 20001to support the development of local cultural undertakings.

In July 2000, the company donated 50,000 yuan to Wuxi Courageous Award Foundation.

On June 5438+ 10, 2004, the second Huarui Medical Science and Technology Award in Wuxi presented 16 the scientific and technological achievement award and the new technology introduction award to the elites in Wuxi medical field, and the company invested 220,000 yuan.

Since 1994, the company has started to set up university scholarships, covering all the universities over the years 15, with a total scholarship of about 800,000 yuan. Huarui's foreign shareholder, Fei Sen Yuska Company, is a wholly-owned subsidiary of Yuska Group in Fei Sen, a leader in the field of infusion therapy and clinical nutrition in Europe, a leader in its most important markets-Latin America and Asia-Pacific, and one of the major suppliers of intravenous infusion drugs in the United States.

Feika company is committed to the treatment and nursing of severe patients and chronic patients inside and outside the hospital.

Fei Sen Yuska Company currently has more than 20,000 employees and a global network including 55 sales organizations and 55 production bases. In 2008, the company achieved sales of 2.495 billion euros and operating profit of 443 million euros.

China Pharmaceutical Group Co., Ltd., the major Chinese shareholder of Huarui Pharmaceutical Co., Ltd., was established on1June 26th, 998, 165438. It is the largest pharmaceutical enterprise group in China, mainly managed by the central government, focusing on pharmaceutical scientific research, production and service trade. It owns ten wholly-owned or holding subsidiaries and two listed companies, Sinopharm Holdings and Shenzhen Yi Tong. In 2007, the sales revenue was 37.3 billion yuan, and the import and export volume was 770 million dollars. In the ranking of large enterprises in China published by the National Bureau of Statistics in 2006, China Pharmaceutical Group ranked 99th. In 15 1 central enterprises, the sales revenue ranks 55th and the profit ranks 7 1.

China Pharmaceutical Group Company adheres to the corporate philosophy of "caring for life and health" and is committed to building a leading pharmaceutical group with international competitiveness. In China, it has production enterprises, scientific research and design institutes, medicinal materials planting bases and marketing networks covering large and medium-sized cities across the country. Since 1980, 22 Sino-foreign joint venture pharmaceutical production enterprises have been established in cooperation with famous foreign multinational pharmaceutical companies, which has effectively promoted the improvement of the management level of pharmaceutical production and operation in China.

China Pharmaceutical Group has also established trade cooperation relations with thousands of enterprises in more than 100 countries and regions in the world, and has subsidiaries or offices in Hongkong, Vietnam, Germany, the United States and relevant countries and regions in Africa. Now we are gradually completing the transformation from domestic market-oriented operation to transnational operation.

In the earthquake relief in 2008, China Pharmaceutical Group responded quickly and went all out to complete the allocation of medical materials for earthquake relief of 300 million yuan, which played an important role at a critical moment.